Study ID: PM030

Study Title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)

Teva Identifier

PM030

ClinicalTrials.gov Identifier

NCT00856635

Study Status

Completed

Trial Condition(s)

Optic Neuritis

Interventions

Drug: Glatiramer Acetate | Drug: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
inflammation and infections icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 45 Years

Trial Duration

02/01/2009 - 02/01/2011

Phase

Phase 3

Study Type

Interventional